News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Genzyme Corporation First Phase of Job Cuts Will Eliminate 392 Positions
November 5, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Genzyme Corp. said it implemented yesterday the first phase of a previously announced job cut program. The first phase will cut 392 positions, the company said in a regulatory filing.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
People
MORE ON THIS TOPIC
Layoff Tracker
Rampart Shuts Down, InflaRx cuts 30% of Staff
January 12, 2026
·
41 min read
·
BioSpace Editorial Staff
Policy
Flagship CEO Calls Out Attacks on Science, Warns of China Dominance
January 12, 2026
·
4 min read
·
Heather McKenzie
Career Advice
The Top 12 Companies Hiring in Biopharma Now
January 8, 2026
·
1 min read
·
Chantal Dresner
Layoffs
Biopharmas Axed 47% More Employees Year Over Year
January 8, 2026
·
5 min read
·
Angela Gabriel